Boaquina, Jacky Lyn B.
HRN: 24-31-95 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/04/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/04/2024
01/11/2024
IV
600mg
Q8hrs
Infected Breast Mass
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes